Nascent Biotech OTC Stock Forecast - Simple Moving Average
NBIO Stock | USD 0.06 0.0002 0.32% |
The Simple Moving Average forecasted value of Nascent Biotech on the next trading day is expected to be 0.06 with a mean absolute deviation of 0.01 and the sum of the absolute errors of 0.30. Nascent OTC Stock Forecast is based on your current time horizon.
Nascent |
Nascent Biotech Simple Moving Average Price Forecast For the 3rd of December
Given 90 days horizon, the Simple Moving Average forecasted value of Nascent Biotech on the next trading day is expected to be 0.06 with a mean absolute deviation of 0.01, mean absolute percentage error of 0.000066, and the sum of the absolute errors of 0.30.Please note that although there have been many attempts to predict Nascent OTC Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Nascent Biotech's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Nascent Biotech OTC Stock Forecast Pattern
Backtest Nascent Biotech | Nascent Biotech Price Prediction | Buy or Sell Advice |
Nascent Biotech Forecasted Value
In the context of forecasting Nascent Biotech's OTC Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Nascent Biotech's downside and upside margins for the forecasting period are 0.0006 and 11.56, respectively. We have considered Nascent Biotech's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Moving Average forecasting method's relative quality and the estimations of the prediction error of Nascent Biotech otc stock data series using in forecasting. Note that when a statistical model is used to represent Nascent Biotech otc stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.AIC | Akaike Information Criteria | 104.8032 |
Bias | Arithmetic mean of the errors | -4.0E-4 |
MAD | Mean absolute deviation | 0.0051 |
MAPE | Mean absolute percentage error | 0.0797 |
SAE | Sum of the absolute errors | 0.2981 |
Predictive Modules for Nascent Biotech
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Nascent Biotech. Regardless of method or technology, however, to accurately forecast the otc stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the otc stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Other Forecasting Options for Nascent Biotech
For every potential investor in Nascent, whether a beginner or expert, Nascent Biotech's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Nascent OTC Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Nascent. Basic forecasting techniques help filter out the noise by identifying Nascent Biotech's price trends.View Nascent Biotech Related Equities
Risk & Return | Correlation |
Nascent Biotech Technical and Predictive Analytics
The otc stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Nascent Biotech's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Nascent Biotech's current price.Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Nascent Biotech Market Strength Events
Market strength indicators help investors to evaluate how Nascent Biotech otc stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Nascent Biotech shares will generate the highest return on investment. By undertsting and applying Nascent Biotech otc stock market strength indicators, traders can identify Nascent Biotech entry and exit signals to maximize returns.
Accumulation Distribution | 0.17 | |||
Daily Balance Of Power | (0.02) | |||
Rate Of Daily Change | 1.0 | |||
Day Median Price | 0.0564 | |||
Day Typical Price | 0.0582 | |||
Market Facilitation Index | 0.0108 | |||
Price Action Indicator | 0.0053 | |||
Period Momentum Indicator | (0.0002) |
Nascent Biotech Risk Indicators
The analysis of Nascent Biotech's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Nascent Biotech's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting nascent otc stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Mean Deviation | 6.85 | |||
Semi Deviation | 7.96 | |||
Standard Deviation | 11.42 | |||
Variance | 130.31 | |||
Downside Variance | 137.6 | |||
Semi Variance | 63.39 | |||
Expected Short fall | (9.20) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Pair Trading with Nascent Biotech
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Nascent Biotech position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nascent Biotech will appreciate offsetting losses from the drop in the long position's value.Moving against Nascent OTC Stock
0.63 | REGN | Regeneron Pharmaceuticals | PairCorr |
0.62 | NVO | Novo Nordisk AS | PairCorr |
0.62 | NONOF | Novo Nordisk AS | PairCorr |
0.57 | QSAM | Qsam Biosciences | PairCorr |
0.45 | CSLLY | CSL | PairCorr |
The ability to find closely correlated positions to Nascent Biotech could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Nascent Biotech when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Nascent Biotech - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Nascent Biotech to buy it.
The correlation of Nascent Biotech is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Nascent Biotech moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Nascent Biotech moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Nascent Biotech can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Nascent OTC Stock
Nascent Biotech financial ratios help investors to determine whether Nascent OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Nascent with respect to the benefits of owning Nascent Biotech security.